TITLE

HIV Regulatory and Accessory Proteins: New Targets for Vaccine Development

AUTHOR(S)
Robert-Guroff, Marjorie
PUB. DATE
September 2002
SOURCE
DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p597
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduces a series of articles on the development of vaccines which target HIV regulatory and accessory proteins. on cellular immune responses. Importance of potential deleterious or immune suppressive effects of functional regulatory and accessory proteins; Strategy for a Tat-based therapeutic vaccine that incorporates Tat toxoid and interferon-[subalpha].
ACCESSION #
7411865

 

Related Articles

  • HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials. Fanales-Belasio, Emanuele; Cafaro, Aurelio; Cara, Andrea; Negri, Donatella R.M.; Fiorelli, Valeria; Butto, Stefano; Moretti, Sonia; Maggiorella, Maria Teresa; Baroncelli, Silvia; Michelini, Zuleika; Tripiciano, Antonella; Sernicola, Leonardo; Scoglio, Arianna; Borsetti, Alessandra; Ridolfi, Barbara; Bona, Roberta; ten Haaft, Peter; Macchia, Iole; Leone, Pasqualina; Pavone-Cossut, Maria Rosaria // DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p599 

    Vaccination against human immunodeficiency virus (HIV)-1 infection requires candidate antigen(s) (Ag) capable of inducing an effective, broad, and long-lasting immune response against HIV-1 despite mutation events leading to differences in virus clades. The HIV-1 Tat protein is more conserved...

  • Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon. Oka, T; Sastry, K J; Nehete, P; Schapiro, S J; Guo, J Q; Talpaz, M; Arlinghaus, R B // Leukemia (08876924);Feb98, Vol. 12 Issue 2, p155 

    Interferon-alpha treatment induces complete cytogenetic remission in 25% of Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) patients. These remissions are durable unlike remissions induced with other therapies and yet residual leukemia is detectable in most of these...

  • Env mutations conferring improved entry efficiency allow HIV to replicate in the presence of IFN. Rato, Sylvie; Vanwalscappel, Bénédicte; Mammano, Fabrizio // Retrovirology;2013, Vol. 10 Issue Suppl 1, p1 

    An abstract on a study that describes the mutations of emerging viral variant Env which allow HIV replication in the presence of type-1 Interferon (IFN) is presented.

  • Targeting Tat and IFNα as a Therapeutic AIDS Vaccine. Gallo, R.C.; Burny, A.; Zagury, D. // DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p611 

    Evolution to AIDS is characterized by a progressive cellular immune suppression. Although there is substantial evidence for several mechanisms involved in disrupting the immune response by induction of apoptosis in responder cells by contact with infected cells, we propose that humoral factors...

  • Optimal Antigens for HIV Vaccines Based on CD8+ T Response, Protein Length, and Sequence Variability. Betts, Michael R.; Yusim, Karina; Koup, Richard A. // DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p665 

    The identification of optimal antigens to include in an HIV vaccine designed to elicit a cellular immune response requires careful consideration of protein length, variability, and immunogenicity. Here, we have examined the relationship of these parameters in a cohort of HIV-infected subjects....

  • The HIV-1 Accessory Gene vpr Can Inhibit Antigen-Specific Immune Function. Muthumani, Karuppiah; Hwang, Daniel S.; Dayes, Nathaniel S.; Kim, J. Joseph; Weiner, David B. // DNA & Cell Biology;Sep2002, Vol. 21 Issue 9, p689 

    The 14-kDa HIV-1 accessory gene vpr has been reported to have effects on host cell biology. These activities include inhibition of cell proliferation, inhibition of NF-κB activation, inhibition of CD4 T-cell proliferation, and induction of apoptosis in tissue culture. This collection of...

  • Requirement for microtubule integrity in the SOCS1-mediated intracellular dynamics of HIV-1 Gag Nishi, Mayuko; Ryo, Akihide; Tsurutani, Naomi; Ohba, Kenji; Sawasaki, Tatsuya; Morishita, Ryo; Perrem, Kilian; Aoki, Ichiro; Morikawa, Yuko; Yamamoto, Naoki // FEBS Letters;Apr2009, Vol. 583 Issue 8, p1243 

    Abstract: Suppressor of cytokine signaling 1 (SOCS1) is a recently identified host factor that positively regulates the intracellular trafficking and stability of HIV-1 Gag. We here examine the molecular mechanism by which SOCS1 regulates intercellular Gag trafficking and virus particle...

  • Regulatory and Accessory HIV-1 Proteins: Potential Targets for HIV-1 Vaccines? Yu, X. G.; Lichterfeld, M.; Addo, M. M.; Altfeld, M. // Current Medicinal Chemistry;2005, Vol. 12 Issue 6, p741 

    The HIV-1 regulatory proteins Tat and Rev and the accessory proteins Vpr, Vpu and Vif are essential for efficient viral replication, and their cytoplasmic production suggests that they should be processed for recognition by cytotoxic T lymphocytes. However, only limited data is available,...

  • Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial. Haynes, Barton F.; Gilbert, Peter B.; McElrath, M. Juliana; Zolla-Pazner, Susan; Tomaras, Georgia D.; Alam, S. Munir; Evans, David T.; Montefiori, David C.; Karnasuta, Chitraporn; Sutthent, Ruengpueng; Liao, Hua-Xin; DeVico, Anthony L.; Lewis, George K.; Williams, Constance; Pinter, Abraham; Fong, Youyi; Janes, Holly; DeCamp, Allan; Huang, Yunda; Rao, Mangala // New England Journal of Medicine;4/5/2012, Vol. 366 Issue 14, p1275 

    Background: In the RV144 trial, the estimated efficacy of a vaccine regimen against human immunodeficiency virus type 1 (HIV-1) was 31.2%. We performed a case�control analysis to identify antibody and cellular immune correlates of infection risk. Methods: In pilot studies conducted with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics